View Older Stories View More Recent Stories
-
Abbott Labs (ABT) PT Raised to $158 at Barclays
-
Abbott Labs (ABT) PT Raised to $138 at Bernstein, Citing 'Strong Momentum'
-
Abbott Labs (ABT) PT Raised to $148 at UBS
-
Abbott Labs (ABT) PT Raised to $135 at Stifel
-
Abbott Labs (ABT) PT Raised to $140 at BTIG
-
Abbott Labs (ABT) PT Raised to $140 at BTIG
-
Abbott (ABT) Reports In-Line Q4 EPS; offers guidance
-
Abbott (ABT) call put ratio 3.4 calls to 1 put with a focus on January 31 weekly 121 calls into quarter results
-
US To Ban Red Dye No. 3 In Food As Soon As Wednesday: Sources - Bloomberg
-
Abbott Labs (ABT) PT Raised to $135 at TD Cowen
-
RBC's Best Picks For 2025 in Medical Supplies & Devices: 'Oasis of Opportunity Awaits as MedTech Momentum Continues'
-
Abbott (ABT) Declares $0.59 Quarterly Dividend; 2.1% Yield
-
RBC comments on medical devices sector ahead of EW's Investor Day
-
Is Trump 2.0 good or bad for healthcare stocks?
-
Barclays highlights most and least sensitive MedTech stocks to changes in surgical volumes
-
Abbott Labs (ABT) PT Raised to $149 at Barclays
-
Abbott (ABT), Reckitt Unit Defeat Infant-formula Sickness Claims - Bloomberg
-
Abbott and the Big Ten Conference Tackle U.S. Blood Shortages With First-of-Its-Kind, Nationwide Blood Donation Competition, 'The We Give Blood Drive'
-
Abbott Labs (ABT) PT Raised to $133 at Piper Sandler
-
Oppenheimer Reiterates Outperform Rating on Abbott Labs (ABT)
-
TD Cowen Reiterates Buy Rating on Abbott Labs (ABT)
-
JPMorgan Reiterates Overweight Rating on Abbott Labs (ABT)
-
Abbott Labs (ABT) PT Raised to $125 at Jefferies
-
Abbott Labs (ABT) PT Raised to $130 at Stifel
-
Abbott Labs (ABT) PT Raised to $128 at Evercore ISI
-
Abbott Labs (ABT) PT Raised to $139 at BTIG
-
CFRA Reiterates Buy Rating on Rio Tinto Plc. (RIO:LN) (RIO)
-
Abbott (ABT) Tops Q3 EPS by 1c, Offers Guidance
-
Abbott (ABT) October option implied volatility into quarter results
-
Abbott (ABT) October 117 straddle priced for a move of 3.5% into the expected release before the b
-
Citi Reiterates Buy Rating on Abbott Labs (ABT)
-
Abbott Labs (ABT) PT Raised to $135 at JPMorgan
-
Oppenheimer Starts Abbott Labs (ABT) at Outperform
-
TD Cowen Reiterates Buy Rating on Abbott Labs (ABT)
-
Abbott (ABT) Declares $0.55 Quarterly Dividend; 1.9% Yield
-
Piper Sandler Starts Abbott Labs (ABT) at Overweight
-
TD Cowen Reiterates Buy Rating on Abbott Labs (ABT)
-
Abbott (ABT) Expands its Pure Bliss Line of Infant Formulas to Include European-Made and Organic Products
-
Jefferies Reiterates Hold Rating on Abbott Labs (ABT)
-
3 ways to gain stock market exposure to the fertility theme
-
BTIG Reiterates Buy Rating on Abbott Labs (ABT)
-
Selloff in MedTech stocks 'seems overdone': Citi
-
Abbott (ABT) Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices
-
Abbott Teams Up With the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health
-
Midday movers: McDonald's, Tesla, Onsemi rise; Abbott falls
-
These stocks offer you exposure to rising demand for fertility treatment – Barclays
-
UBS Reiterates Buy Rating on Abbott Labs (ABT)
-
BTIG Reiterates Buy Rating on Abbott Labs (ABT)
-
Midday movers: DR Horton, Kinder Morgan rise ; Domino's Pizza, Beyond Meat fall
-
Evercore ISI Reiterates Outperform Rating on Abbott Labs (ABT), PT $120

